JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
-
Blueprint Medicines to Present at Upcoming Investor Conferences
-
Blueprint Medicines to Present at Upcoming Investors Conferences
-
Blueprint Medicines (BPMC) Prices 4.71M Share Common Offering at $69/Sh
-
Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock
-
Blueprint Medicines (BPMC) Announces Proposed $325M Public Offering of Shares of Common Stoc
-
Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock
-
Blueprint Medicines (BPMC) PT Lowered to $103 at JMP Securities
-
Blueprint Medicines (BPMC) PT Raised to $109 at JMP Securities
-
Blueprint Medicines (BPMC) PT Raised to $97 at JMP Securities Following Positive Phase 1 Update for Avapritinib at ASH Conference
-
Blueprint Medicines (BPMC): Raising PT on Phase I Dosing - JMP
-
Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock
-
Blueprint Medicines (BPMC) Prices $125M Common Stock Offering
-
Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock
-
Blueprint Medicines (BPMC) to Offer $125M of Common Stock
-
Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock
-
Blueprint Medicines to Present at Upcoming Investor Conferences in June
-
Blueprint Medicines to Present at Upcoming Investor Conferences in June
-
JMP Securities Starts Blueprint Medicines (BPMC) at Market Outperform
-
Blueprint Medicines Announces Closing of Initial Public Offering
-
Blueprint Medicines (BPMC) IPO Opens Up 30%
-
Blueprint Medicines Announces Pricing of Initial Public Offering
-
Blueprint Medicines Files Registration Statement for Proposed Initial Public Offering
-
Blueprint Medicines (BPMC) Files $100M IPO

